1545 SEXUAL FUNCTION FOLLOWING TVT-O PLACEMENT: MINIMUM 12 MONTH FOLLOW UP

Abstract

You have accessJournal of UrologyUrodynamics/Incontinence/Female Urology: Female Urology I1 Apr 20121545 SEXUAL FUNCTION FOLLOWING TVT-O PLACEMENT: MINIMUM 12 MONTH FOLLOW UP Ashley King, Jeffrey Wolters, Adam Klausner, and David Rapp Ashley KingAshley King Richmond, VA More articles by this author , Jeffrey WoltersJeffrey Wolters Richmond, VA More articles by this author , Adam KlausnerAdam Klausner Richmond, VA More articles by this author , and David RappDavid Rapp Richmond, VA More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2012.02.1315AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES The effect of anti-incontinence surgery on sexual function is not clear based on the current literature. The study aim was to examine the impact of TVTO on sexual function and vaginal symptoms. Assessment of these outcomes is increasingly important given recent FDA warning regarding the use of surgical mesh for repair of stress urinary incontinence. METHODS A retrospective review of 42 patients undergoing TVTO with a minimum of 12 month follow-up was performed. Outcomes were assessed at baseline and 12-months post-operatively using validated questionnaires, with focus on the International Consultation on Incontinence Questionnaire-Vaginal Symptoms (ICIQ-VS). The ICIQ-VS is a validated measure assessing the impact of vaginal symptoms and associated sexual matters on quality of life and treatment outcomes. The Incontinence Impact Questionnaire (IIQ-7) was used to assess quality of life. Additional binary and scaled items assessed satisfaction and degree of improvement, respectively. RESULTS Mean age and parity was 61.6 years and 2.1, respectively. Average follow up was 24.7 months. Statistically significant improvements were seen in vaginal symptoms (9.7 to 6.0, p=0.01), sexual matters (16.7 to 6.9, p=0.01), and quality of life (3.0 to 1.1, p=0.001) domains on ICIQ-VS assessment at baseline versus 12-month comparison. Eighteen of 20 sexually active patients at baseline reported continued sexual activity postoperatively, with two patients reporting absence of sexual activity due to other factors. Two patients not sexually active at baseline due to vaginal symptoms reported resuming sexual activity at one year. Statistically significant improvement in vaginal soreness and a trend toward improvement in the abdominal pain domain score was seen in comparison of baseline and 1-year points. CONCLUSIONS TVT-O sling placement was associated with improvements in validated measures of sexual function and vaginal symptoms. The vast majority of patients reported symptom stability or improvement in these endpoints. Therefore, these findings did not support concerns regarding worsening sexual function and vaginal symptoms after TVT-O sling placement. © 2012 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 187Issue 4SApril 2012Page: e625 Advertisement Copyright & Permissions© 2012 by American Urological Association Education and Research, Inc.MetricsAuthor Information Ashley King Richmond, VA More articles by this author Jeffrey Wolters Richmond, VA More articles by this author Adam Klausner Richmond, VA More articles by this author David Rapp Richmond, VA More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...